<?xml version='1.0' encoding='utf-8'?>
<document id="15550721"><sentence text="In vitro and in vivo correlation of the inhibitory effect of cyclosporin A on the transporter-mediated hepatic uptake of cerivastatin in rats."><entity charOffset="61-74" id="DDI-PubMed.15550721.s1.e0" text="cyclosporin A" /><entity charOffset="121-133" id="DDI-PubMed.15550721.s1.e1" text="cerivastatin" /><pair ddi="false" e1="DDI-PubMed.15550721.s1.e0" e2="DDI-PubMed.15550721.s1.e0" /><pair ddi="false" e1="DDI-PubMed.15550721.s1.e0" e2="DDI-PubMed.15550721.s1.e1" /></sentence><sentence text="Previously, we have shown that the inhibition of the transporter-mediated hepatic uptake of cerivastatin (CER) by cyclosporin A (CsA) could, at least partly, explain a pharmacokinetic interaction between these drugs in humans"><entity charOffset="92-104" id="DDI-PubMed.15550721.s2.e0" text="cerivastatin" /><entity charOffset="114-127" id="DDI-PubMed.15550721.s2.e1" text="cyclosporin A" /><entity charOffset="129-132" id="DDI-PubMed.15550721.s2.e2" text="CsA" /><pair ddi="false" e1="DDI-PubMed.15550721.s2.e0" e2="DDI-PubMed.15550721.s2.e0" /><pair ddi="false" e1="DDI-PubMed.15550721.s2.e0" e2="DDI-PubMed.15550721.s2.e1" /><pair ddi="false" e1="DDI-PubMed.15550721.s2.e0" e2="DDI-PubMed.15550721.s2.e2" /><pair ddi="false" e1="DDI-PubMed.15550721.s2.e1" e2="DDI-PubMed.15550721.s2.e1" /><pair ddi="false" e1="DDI-PubMed.15550721.s2.e1" e2="DDI-PubMed.15550721.s2.e2" /></sentence><sentence text=" In the present study, we have examined the effect of CsA on the in vivo disposition of CER in rats and the in vitro uptake of [14C]CER in isolated rat hepatocytes in an attempt to evaluate the effect of inhibition of transporter-mediated hepatic uptake on the in vivo CER disposition"><entity charOffset="54-56" id="DDI-PubMed.15550721.s3.e0" text="CsA" /></sentence><sentence text=" The steady-state plasma concentration of CER increased 1" /><sentence text="4-fold when coadministered with CsA up to a steady-state blood concentration of 4 microM"><entity charOffset="32-34" id="DDI-PubMed.15550721.s5.e0" text="CsA" /></sentence><sentence text=" Studies of [14C]CER uptake into isolated rat hepatocytes showed saturable transport, with the saturable portion accounting for more than 80% of the total uptake" /><sentence text=" CsA competitively inhibited the uptake of [14C]CER with a Ki of 0"><entity charOffset="1-3" id="DDI-PubMed.15550721.s7.e0" text="CsA" /></sentence><sentence text="3 microM" /><sentence text=" The IC50 for the uptake of [14C]CER in the absence and presence of rat plasma was 0" /><sentence text="2 and 2" /><sentence text="3 microM, respectively" /><sentence text=" The in vivo hepatic uptake of [14C]CER evaluated by the liver uptake index method was also inhibited by CsA in a dose-dependent manner"><entity charOffset="105-107" id="DDI-PubMed.15550721.s12.e0" text="CsA" /></sentence><sentence text=" On the other hand, CsA did not inhibit the metabolism of [14C]CER in rat microsomes"><entity charOffset="20-22" id="DDI-PubMed.15550721.s13.e0" text="CsA" /></sentence><sentence text=" The in vitro and in vivo correlation analysis revealed that this pharmacokinetic interaction between these drugs in rats could be quantitatively explained by the inhibition of transporter-mediated hepatic uptake" /><sentence text=" Thus, this drug-drug interaction in rats is predominantly caused by the transporter-mediated uptake process" /><sentence text="" /></document>